Found: 18
Select item for more details and to access through your institution.
Precision Oncology—The Quest for Evidence.
- Published in:
- Journal of Personalized Medicine, 2019, v. 9, n. 3, p. 43, doi. 10.3390/jpm9030043
- By:
- Publication type:
- Article
Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.
- Published in:
- Pharmaceuticals (14248247), 2019, v. 12, n. 4, p. 141, doi. 10.3390/ph12040141
- By:
- Publication type:
- Article
Arena3D: visualization of biological networks in 3D.
- Published in:
- BMC Systems Biology, 2008, v. 2, p. 1, doi. 10.1186/1752-0509-2-104
- By:
- Publication type:
- Article
Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3895, doi. 10.3390/ijms21113895
- By:
- Publication type:
- Article
Biggest challenges in bioinformatics.
- Published in:
- EMBO Reports, 2013, v. 14, n. 4, p. 302, doi. 10.1038/embor.2013.34
- By:
- Publication type:
- Article
Martini: using literature keywords to compare gene sets.
- Published in:
- Nucleic Acids Research, 2010, v. 38, n. 1, p. 26, doi. 10.1093/nar/gkp876
- By:
- Publication type:
- Article
Caipirini: using gene sets to rank literature.
- Published in:
- BioData Mining, 2012, v. 5, n. 1, p. 1, doi. 10.1186/1756-0381-5-1
- By:
- Publication type:
- Article
Using graph theory to analyze biological networks.
- Published in:
- BioData Mining, 2011, v. 4, n. 1, p. 10, doi. 10.1186/1756-0381-4-10
- By:
- Publication type:
- Article
A reference guide for tree analysis and visualization.
- Published in:
- BioData Mining, 2010, v. 3, p. 1, doi. 10.1186/1756-0381-3-1
- By:
- Publication type:
- Article
Adverse Event Circumstances and the Case of Drug Interactions.
- Published in:
- Healthcare (2227-9032), 2019, v. 7, n. 1, p. 45, doi. 10.3390/healthcare7010045
- By:
- Publication type:
- Article
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1008, doi. 10.3390/cancers12041008
- By:
- Publication type:
- Article
LAITOR -- Literature Assistant for Identification ofTerms co-Occurrences and Relationships.
- Published in:
- BMC Bioinformatics, 2010, v. 11, p. 70, doi. 10.1186/1471-2105-11-70
- By:
- Publication type:
- Article
Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 5, p. 1232, doi. 10.1002/cpt.2074
- By:
- Publication type:
- Article
Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 5, p. 540, doi. 10.1002/psp4.12765
- By:
- Publication type:
- Article
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data.
- Published in:
- Diagnostics (2075-4418), 2018, v. 8, n. 4, p. 76, doi. 10.3390/diagnostics8040076
- By:
- Publication type:
- Article
Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 6, p. 1430, doi. 10.1111/cts.13254
- By:
- Publication type:
- Article
A case study of a patient‐centered reverse translational systems‐based approach to understand adverse event profiles in drug development.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 4, p. 1003, doi. 10.1111/cts.13219
- By:
- Publication type:
- Article
Association Between Serotonin Syndrome and Second‐Generation Antipsychotics via Pharmacological Target‐Adverse Event Analysis.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 3, p. 322, doi. 10.1111/cts.12543
- By:
- Publication type:
- Article